Working at the cutting edge of clinical data, AI and complex trials? 🤖 CCDS is SCDM’s most advanced certification launching this Spring. It recognizes professionals who use simulations, predictive models and modern methodologies in complex CDM environments. Learn more: scdm.org/ccds-certification/

📢 Final call to contribute to the GCDMP© “Clinical Trial Database Lock” chapter opened for public review only until March 20. scdm.org/gcdmp/#GCDMP-public…

You’ve built experience in Clinical Data Management. 🎓CCDM® sets a recognized standard of excellence for CDM professionals with 2–4 years of experience, helping you stand out as trials become more connected, digital and complex. Learn more about the CCDM® program and application process: scdm.org/ccdm-certification/

If you work in #clinicaldata, #clinicalresearch or #clinicaldatascience, share your comments on the GCDMP chapter on Database Lock and and help shape how it is defined. ✍️ Review the chapter and share your feedback by March 20, 2026 🔗 scdm.org/gcdmp/#GCDMP-public…

New(ish) to Clinical Data Management? 🎓 The CCDA certification is designed for professionals with 0–2 years of CDM experience, helping you solidify your foundations and show you’re ready for modern, data‑driven studies. Learn more about CCDA and apply: scdm.org/ccda-certification/

The JSCDM Winter Issue is out! ❄️ We’re entering what Ward Lemaire called the “Golden Era of Data,” and clinical data professionals are leading the transformation. Inside you'll find: ➜ Patient‑centered trial design ➜ Ethical LLM use ➜ Standards updates ➜AI governance, RWD, FAIR data and more Explore the Issue: jscdm.org/issue/37/info/ @TakuhiroBiostat

📝 Did you get the chance to review the GCDMP© chapter “Clinical Trial Database Lock” yet? If not, there is still time. Before the weekend kicks in, take a few minutes to dive into one of the most critical steps in the clinical trial lifecycle - Database lock: the point where data integrity, statistical analyses, and regulatory submissions all depend on getting it right. We need your expertise to make sure the chapter is accurate, applicable, and aligned with how DB lock is handled across today’s studies. ✏️ Add your voice and submit your comments before March 20: scdm.org/gcdmp/#GCDMP-public…

Which SCDM Certification is right for you? Whether you’re just starting your journey in Clinical Data Management or already leading complex data projects, there’s an SCDM certification designed to match your career stage. Are you just starting in CDM field? Start with CCDA. Are you already experienced professional? Consider CCDM. Are you working with complex simulations? Advance with CCDS (coming soon). Read more about each program and see which one fits your goals, experience and level. 👉scdm.org/certification/

📢 The GCDMP© chapter “Clinical Trial Database Lock” is now open for public review! If you work in #clinicaldata, contribute with your experience and expertise to shape the guidelines that provide reference and benchmark for data managers worldwide. scdm.org/gcdmp/#GCDMP-public…

And we're LIVE! We started with Ward Lemaire's introduction and walk-through of the Vision 2030 giving us clear overview what we can expect. We'll move slowly to our line up of panelists: Tanya du Plessis, Chris Decker, Marilyn Neault and Wayne Walker to share their views on the vision and answer your burning questions about the state of the #CDM industry. If you're not tuned-in yet, make haste and join us now: 0q1kr.mjt.lu/wgt/0q1kr/058m/… Cannot make it to the live session? We'll share the webinar on-demand for you to rewatch.

We're live in 10 minutes! If you want to hear Ward Lemaire, our new SCDM Chair 2026 and a line-up of panelists Tanya du Plessis, Chris Decker, Marilyn Neault and Wayne Walker to talk about Vision 2030, join us, ask questions and let's see together where #CDM industry is headed. See you there: 0q1kr.mjt.lu/wgt/0q1kr/058m/…

A recent JSCDM study asked participants what truly shapes their experience in clinical trials and the answers challenge common assumptions. Missed this insight? It’s worth a closer look. 📖 Read the full article on #JSCDM: jscdm.org/article/id/441/

What really keeps participants engaged in clinical trials? A new #JSCDM study finds it’s not just tech or convenience, it's: clear communication, trust, respect, and feeling supported. Decentralized trials offer flexibility. Traditional trials bring human connection. Across both, transparency matters most. Read more: jscdm.org/article/id/441/

Can #AI really change how we run clinical trials? Our latest Digital First article explores how Large Language Models like ChatGPT can: ✅ Automate SOPs & documentation ✅ Support compliance workflows ✅ Balance efficiency with ethics AI isn’t just hype - it’s a tool for agile, patient-focused research. 📖 Read more: jscdm.org/article/id/438/

What does clinical data science look like in a year or two? What about in 2030? At the #SCDM 2025 Japan Conference, Ward Lemaire, Head of Data Management & Central Monitoring at Johnson & Johnson Innovative Medicine, and incoming SCDM Chair, will share where our industry is heading in the next five years and how #SCDM will support this journey for clinical data professionals across the globe. During his keynote, Ward will share a first glimpse into SCDM’s future-focused vision for 2030 which includes building partnerships and collaborations, transforming education, and expanding our global reach. All of this unified around one shared vision: to lead clinical data for a healthier world. If you believe in a future where clinical data drives better health for all - our vision is your call to action. 📍 Join us at #SCDM 2025 Japan Conference: scdmlive.org/japan-conferenc…

The SCDM 2026 EMEA Conference theme - Bridge Ideas, Build Futures - draws inspiration from Copenhagen’s iconic bridges, like the Øresund Bridge linking Denmark and Sweden. Just as bridges connect cities and communities, our work in clinical data connects systems, teams, and ultimately, patients. This year, we’ll explore how stronger connections - between fragmented data sources, cross-functional teams, and the patient journey - can lead to smarter, more inclusive clinical trials. Copenhagen is where we will meet for #EMEA26, where conversations will spark new ways of working, and collaboration turns into action. Join us on 3-6 May 2026 to share your perspective, learn from others, and help build a more connected approach to clinical data: scdmlive.org/emea-conference…

AI-Powered Oversight Starts with Smarter Workflows As Annexes 2 and 3 approach, clinical data teams must evolve from delegation to independent oversight. During the next #SCDM industry webinar brought to you by @RevvitySignals , Christie Quarles, Philip Ross and Brent Meyers will explore how AI and automation are transforming how we detect risks, generate CtQ listings, and document decisions, without writing a single line of code. If you’re navigating inspections, oversight, or AI-powered workflows, this session is your roadmap.🔗 Save your spot: register.gotowebinar.com/reg…

Oversight Isn’t Optional Anymore. Are You Inspection-Ready? ICH E6(R3) is reshaping how sponsors approach oversight and inspectors are watching closely. In this hands-on webinar from @RevvitySignals, three experts - Christie Quarles, Brent Meyers, and Philip Ross - break down what’s already in effect (Principles Annex 1) and preview what’s coming next. This is not just theory but a practical model that clinical data teams can apply immediately: Detect → Decide → Document 🔗 Register now to get the tools, templates, and governance tips you need to build audit-ready workflows: shorturl.at/BWtmm

Your learning. Your way. The new #SCDM Learning Experience Platform - elev8 - is more than a library of courses. It’s a personalized journey that adapts to your pace and goals. It's interactive and makes concepts stick. It's ready to provide on-the-spot answers. It's built around the CDM Competency Framework. And it's filled with content designed and curated by #CDM industry experts. Ready to start a learning journey that’s built around you? Explore elev8 👉scdm.org/knowledge/#elev8-at…

Explore the #regulatory and #operational dimensions of biospecimen data governance in a new podcast episode. In this sponsored episode, originally produced by Slope, Rust Felix CEO and Co-founder of Slope, sits down with legal and regulatory expert Edye Edens to unpack a critical — and often overlooked — aspect of the newly updated ICH E6(R3) GCP guidelines: biospecimen data. 💡 With EMA enforcement beginning July 23, 2025, this conversation is a must-listen for sponsors still relying on spreadsheets, paper, or disconnected systems to manage biospecimen workflows. Tune in to learn how to future-proof your biospecimen data strategy — and why governance is no longer optional. 🎧 Learn more and stream now➡️ scdm.org/scdm-sponsored-podc…